Garrison Bradford & Associates’s Sensus Healthcare SRTS Stock Holding History

Garrison Bradford & Associates’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,500	Closed	-$49.8K	–	41
2025 Q4	$49.8K	Hold	12,500	–	–	0.05%	33
2025 Q3	$39.3K	Hold	12,500	–	–	0.04%	30
2025 Q2	$59.3K	Hold	12,500	–	–	0.07%	44
2025 Q1	$59.1K	Hold	12,500	–	–	0.07%	42
2024 Q4	$86K	Hold	12,500	–	–	0.09%	31
2024 Q3	$72K	Sell	12,500 -6,400	-34%	-$38.9K	0.07%	30
2024 Q2	$101K	Hold	18,900	–	–	0.1%	30
2024 Q1	$72K	Hold	18,900	–	–	0.07%	31
2023 Q4	$45K	Hold	18,900	–	–	0.05%	31
2023 Q3	$52K	Hold	18,900	–	–	0.06%	31
2023 Q2	$60K	Hold	18,900	–	–	0.07%	33
2023 Q1	$98K	Hold	18,900	–	–	0.12%	37
2022 Q4	$140K	Hold	18,900	–	–	0.17%	41
2022 Q3	$237K	Sell	18,900 -3,000	-14%	-$35.8K	0.29%	39
2022 Q2	$168K	Sell	21,900 -10,000	-31%	-$83.9K	0.19%	43
2022 Q1	$323K	Hold	31,900	–	–	0.31%	38
2021 Q4	$230K	Hold	31,900	–	–	0.21%	47
2021 Q3	$115K	Hold	31,900	–	–	0.12%	49
2021 Q2	$123K	Hold	31,900	–	–	0.13%	49
2021 Q1	$122K	Sell	31,900 -25,500	-44%	-$105K	0.14%	48
2020 Q4	$222K	Sell	57,400 -3,000	-5%	-$9.15K	0.27%	44
2020 Q3	$152K	Sell	60,400 -1,000	-2%	-$2.82K	0.21%	46
2020 Q2	$188K	Hold	61,400	–	–	0.27%	45
2020 Q1	$153K	Hold	61,400	–	–	0.26%	45
2019 Q4	$217K	Buy	61,400 +3,000	+5%	+$13.6K	0.27%	48
2019 Q3	$350K	Sell	58,400 -40,000	-41%	-$233K	0.48%	34
2019 Q2	$545K	Sell	98,400 -10,000	-9%	-$58.6K	0.64%	33
2019 Q1	$761K	Buy	108,400 +79,500	+275%	+$614K	0.65%	34
2018 Q4	$214K	Sell	28,900 -1,100	-4%	-$6.99K	0.19%	64
2018 Q3	$251K	Hold	30,000	–	–	0.2%	57
2018 Q2	$218K	Hold	30,000	–	–	0.18%	64
2018 Q1	$175K	Hold	30,000	–	–	0.15%	66
2017 Q4	$155K	Sell	30,000 -4,000	-12%	-$21.7K	0.13%	74
2017 Q3	$169K	Hold	34,000	–	–	0.14%	73
2017 Q2	$137K	Hold	34,000	–	–	0.12%	74
2017 Q1	$149K	Hold	34,000	–	–	0.13%	74
2016 Q4	$178K	Hold	34,000	–	–	0.16%	69
2016 Q3	$209K	Buy	+34,000	New	+$213K	0.2%	69

Other funds holding SRTS

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MIM

Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

GWM

Greenline Wealth Management Boca Raton, Florida $122M AUM

Garrison Bradford & Associates's SRTS Position: Q1 2026 in Review

Garrison Bradford & Associates sold out of Sensus Healthcare (SRTS) in Q1 2026, closing a stake of 12,500 shares — an estimated $49.8K sold.

Garrison Bradford & Associates first reported a position in SRTS in Q3 2016 and held it in 38 quarters. The position peaked at $761K in Q1 2019. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.

Garrison Bradford & Associates reported no remaining Sensus Healthcare position as of Q1 2026 after selling out during the quarter.
Garrison Bradford & Associates sold 12,500 Sensus Healthcare shares in Q1 2026, an estimated $49.8K.
Garrison Bradford & Associates first reported a position in Sensus Healthcare in Q3 2016 and held it in 38 quarters.
Garrison Bradford & Associates's Sensus Healthcare position peaked at $761K in Q1 2019.
41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.

Based on Garrison Bradford & Associates's 13F filing for Q1 2026, filed 4 May 2026.